Cardiac resynchronization therapy in congenital heart disease
1Children's Heart Centre, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V úvalu 84, 15006, Prague, Czech Republic. jan.janousek@fnmotol.cz.
Insights
Cardiac resynchronization therapy (CRT) shows promise for congenital heart disease (CHD) patients. Efficacy in CHD depends on systemic ventricle anatomy, with best outcomes in those with systemic left ventricles receiving CRT after conventional pacing.
Area of Science:
- Cardiology
- Electrophysiology
- Congenital Heart Disease
Background:
- Cardiac resynchronization therapy (CRT) is effective for heart failure in adults with cardiomyopathy.
- Limited data exists on CRT efficacy in patients with congenital heart disease (CHD).
- CHD presents unique anatomical and functional challenges for CRT implantation.
Purpose of the Study:
- To review the efficacy and implantation considerations of CRT in patients with CHD.
- To highlight the importance of systemic ventricle anatomy in CRT outcomes for CHD.
- To reference expert consensus guidelines on CRT in adult CHD.
Main Methods:
- Review of existing literature on CRT in CHD.
- Analysis of factors influencing CRT efficacy based on systemic ventricle anatomy.
- Discussion of prevailing implantation techniques (thoracotomy, hybrid).
Main Results:
- CRT efficacy in CHD appears dependent on systemic ventricle anatomy.
- Best outcomes were observed in patients with a systemic left ventricle upgraded from conventional pacing.
- Implantation techniques vary due to CHD structural heterogeneity.
Conclusions:
- CRT may be a viable option for select CHD patients.
- Systemic ventricle anatomy is a critical determinant of CRT success in CHD.
- Further research is needed to optimize CRT in the diverse CHD population.
Abstract:
Cardiac resynchronization therapy (CRT) is an established treatment option for adult patients suffering heart failure due to idiopathic or ischemic cardiomyopathy associated with electromechanical dyssynchrony. There is limited evidence suggesting similar efficacy of CRT in patients with congenital heart disease (CHD). Due to the heterogeneity of structural and functional substrates, CRT implantation techniques are different with a thoracotomy or hybrid approach prevailing. Efficacy of CRT in CHD seems to depend on the anatomy of the systemic ventricle with best results achieved in systemic left ventricular patients upgraded to CRT from conventional pacing. Indications for CRT in patients with CHD were recently summarized in the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease and are presented in the text.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...


